1. Home
  2. NTRA vs IOT Comparison

NTRA vs IOT Comparison

Compare NTRA & IOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • IOT
  • Stock Information
  • Founded
  • NTRA 2003
  • IOT 2015
  • Country
  • NTRA United States
  • IOT United States
  • Employees
  • NTRA N/A
  • IOT N/A
  • Industry
  • NTRA Medical Specialities
  • IOT Retail: Computer Software & Peripheral Equipment
  • Sector
  • NTRA Health Care
  • IOT Technology
  • Exchange
  • NTRA Nasdaq
  • IOT Nasdaq
  • Market Cap
  • NTRA 21.7B
  • IOT 20.9B
  • IPO Year
  • NTRA 2015
  • IOT 2021
  • Fundamental
  • Price
  • NTRA $163.02
  • IOT $33.52
  • Analyst Decision
  • NTRA Strong Buy
  • IOT Buy
  • Analyst Count
  • NTRA 16
  • IOT 13
  • Target Price
  • NTRA $193.50
  • IOT $49.46
  • AVG Volume (30 Days)
  • NTRA 1.7M
  • IOT 4.6M
  • Earning Date
  • NTRA 08-07-2025
  • IOT 09-04-2025
  • Dividend Yield
  • NTRA N/A
  • IOT N/A
  • EPS Growth
  • NTRA N/A
  • IOT N/A
  • EPS
  • NTRA N/A
  • IOT N/A
  • Revenue
  • NTRA $1,964,250,000.00
  • IOT $1,335,357,000.00
  • Revenue This Year
  • NTRA $19.98
  • IOT $25.52
  • Revenue Next Year
  • NTRA $16.16
  • IOT $21.81
  • P/E Ratio
  • NTRA N/A
  • IOT N/A
  • Revenue Growth
  • NTRA 44.38
  • IOT 31.72
  • 52 Week Low
  • NTRA $110.57
  • IOT $31.40
  • 52 Week High
  • NTRA $183.00
  • IOT $61.90
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 65.28
  • IOT 38.12
  • Support Level
  • NTRA $152.62
  • IOT $31.68
  • Resistance Level
  • NTRA $161.92
  • IOT $33.09
  • Average True Range (ATR)
  • NTRA 6.11
  • IOT 1.55
  • MACD
  • NTRA 3.42
  • IOT -0.34
  • Stochastic Oscillator
  • NTRA 93.78
  • IOT 21.37

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About IOT Samsara Inc.

Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows.. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers ranges from small and medium-sized businesses to state and local governments.

Share on Social Networks: